Literature DB >> 21460131

Managing newly diagnosed atrial fibrillation: rate, rhythm, and risk.

Thomas Callahan1, Brian Baranowski.   

Abstract

The treatment of atrial fibrillation focuses on controlling the heart rate, preventing thromboembolic events, and, depending on the symptoms, restoring and maintaining sinus rhythm. In most cases, the rate or rhythm can be quickly controlled, and a long-term plan can be started that will minimize the impact of this disorder on the life of the patient.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460131     DOI: 10.3949/ccjm.78a.09165

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  2 in total

1.  A stacked LSTM for atrial fibrillation prediction based on multivariate ECGs.

Authors:  Le Sun; Yukang Wang; Jinyuan He; Haoyuan Li; Dandan Peng; Yilin Wang
Journal:  Health Inf Sci Syst       Date:  2020-04-21

2.  Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.

Authors:  Gerald V Naccarelli; Riccardo Cappato; Stefan H Hohnloser; Francis E Marchlinski; David J Wilber; Jim Xiang; Changsheng Ma; Susanne Hess; David Wyn Davies; Larry E Fields; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2014-07-09       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.